{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:35:05Z","timestamp":1785418505127,"version":"3.56.0"},"posted":{"date-parts":[[2026,5,30]]},"group-title":"Cancer Biology","reference-count":70,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"award":["2018\/30\/M\/NZ3\/00274"],"award-info":[{"award-number":["2018\/30\/M\/NZ3\/00274"]}],"id":[{"id":"https:\/\/ror.org\/03ha2q922","id-type":"ROR","asserted-by":"publisher"}]},{"award":["2021\/41\/B\/NZ5\/04077"],"award-info":[{"award-number":["2021\/41\/B\/NZ5\/04077"]}],"id":[{"id":"https:\/\/ror.org\/03ha2q922","id-type":"ROR","asserted-by":"publisher"}]},{"award":["2020\/39\/I\/ST5\/03473"],"award-info":[{"award-number":["2020\/39\/I\/ST5\/03473"]}],"id":[{"id":"https:\/\/ror.org\/03ha2q922","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["2P30CA006927-56A1"],"award-info":[{"award-number":["2P30CA006927-56A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01GM140735"],"award-info":[{"award-number":["R01GM140735"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["01GM112766"],"award-info":[{"award-number":["01GM112766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1S10OD030363-01A1"],"award-info":[{"award-number":["1S10OD030363-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"award":["Senior Award"],"award-info":[{"award-number":["Senior Award"]}],"id":[{"id":"https:\/\/ror.org\/014geb094","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Chronic myeloid leukemia (CML) is treated with Abl1 tyrosine kinase inhibitors (TKIs). Quiescent cancer cells residing in the bone marrow (BM) can survive the treatment and cause CML relapse. We previously found that a subset of alternative splicing (AS) changes detected in CML cells surviving months of therapy are initiated within hours of treatment onset. Here, we investigated how AS in CML cells is modulated by the human BM microenvironment. By incorporating humanized BM niche models\n                  <jats:italic>in vivo,<\/jats:italic>\n                  we uncovered stroma-induced transcriptome adaptation that influences transcriptional regulation, transmembrane transport, lipid metabolism, the tricarboxylic acid cycle, and respiratory electron transport. We identified RNA-binding protein TIAR (T-cell intracellular antigen-related protein) as a key mediator of CML survival under TKI imatinib treatment. Our data show TIAR-dependent coordination of RNA processing with the metabolic program induced by stromal interaction. Quantitative nascent proteome analysis revealed that TIAR silencing affects the synthesis of metabolic enzymes and proteins involved in imatinib-induced erythroid differentiation. Besides, TIAR knockdown increased lipid peroxidation in untreated cells and decreased reduction potential in cells upon imatinib treatment. Taken together, TIAR deficiency reduces CML survival, possibly by inducing ferroptosis. These findings identify TIAR-dependent RNA processing within the BM niche as a previously unrecognized mechanism of CML therapy resistance and a potential therapeutic vulnerability.\n                <\/jats:p>","DOI":"10.64898\/2026.05.29.728710","type":"posted-content","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:05:36Z","timestamp":1780171536000},"source":"Crossref","is-referenced-by-count":0,"title":["TIAR-dependent coordination of alternative splicing and lipid peroxidation is required for CML cell resistance to imatinib in the bone marrow stroma"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4965-828X","authenticated-orcid":false,"given":"Paulina","family":"Podszywalow-Bartnicka","sequence":"first","affiliation":[{"name":"Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland"},{"name":"Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8655-851X","authenticated-orcid":false,"given":"Ewa","family":"Kozlowska","sequence":"additional","affiliation":[{"name":"Faculty of Biology, University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-3754","authenticated-orcid":false,"given":"Remigiusz","family":"Serwa","sequence":"additional","affiliation":[{"name":"International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-0105","authenticated-orcid":false,"given":"Joanna","family":"Idaszek","sequence":"additional","affiliation":[{"name":"Faculty of Material Science and Engineering, Warsaw University of Technology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2803-4870","authenticated-orcid":false,"given":"Ewa","family":"Walejewska","sequence":"additional","affiliation":[{"name":"Faculty of Material Science and Engineering, Warsaw University of Technology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kepczynska","sequence":"additional","affiliation":[{"name":"Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-8739","authenticated-orcid":false,"given":"Anna","family":"Mietelska-Porowska","sequence":"additional","affiliation":[{"name":"Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3354-439X","authenticated-orcid":false,"given":"Paulina","family":"Pilanc-Kudlek","sequence":"additional","affiliation":[{"name":"Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-9308","authenticated-orcid":false,"given":"Magdalena","family":"Wolczyk","sequence":"additional","affiliation":[{"name":"Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland"},{"name":"International Institute of Molecular and Cellular Biology Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-7609","authenticated-orcid":false,"given":"Leonard","family":"Sch\u00e4rfen","sequence":"additional","affiliation":[{"name":"Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-8994","authenticated-orcid":false,"given":"Bac Viet","family":"Le","sequence":"additional","affiliation":[{"name":"Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4216-9974","authenticated-orcid":false,"given":"Wojciech","family":"Swieszkowski","sequence":"additional","affiliation":[{"name":"Faculty of Material Science and Engineering, Warsaw University of Technology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-5282","authenticated-orcid":false,"given":"Katarzyna","family":"Piwocka","sequence":"additional","affiliation":[{"name":"Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-4538","authenticated-orcid":false,"given":"Tomasz","family":"Skorski","sequence":"additional","affiliation":[{"name":"Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA"},{"name":"Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA"},{"name":"Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-6761","authenticated-orcid":false,"given":"Karla M.","family":"Neugebauer","sequence":"additional","affiliation":[{"name":"Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026071803250437000_2026.05.29.728710v2.1","doi-asserted-by":"crossref","first-page":"96984","DOI":"10.18632\/oncotarget.18904","article-title":"Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"2026071803250437000_2026.05.29.728710v2.2","doi-asserted-by":"crossref","unstructured":"L. Yang , Y. Chen , Y. Wu , The hypoxia signaling pathway in the development of acute myeloid leukemia. Biomed Pharmacother 186, 117999 (2025).","DOI":"10.1016\/j.biopha.2025.117999"},{"key":"2026071803250437000_2026.05.29.728710v2.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018196"},{"key":"2026071803250437000_2026.05.29.728710v2.4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20121484"},{"key":"2026071803250437000_2026.05.29.728710v2.5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ejh.12934","article-title":"Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemia","volume":"99","year":"2017","journal-title":"Eur J Haematol"},{"key":"2026071803250437000_2026.05.29.728710v2.6","doi-asserted-by":"crossref","unstructured":"S. Barachini , M. Montali , I. S. Burzi , E. Pardini , G. S. Infirri , R. C. Cassano , I. Petrini , The role of the bone marrow microenvironment in leukemic stem cell resistance: Pathways of persistence and selection. Crit Rev Oncol Hematol 218, 105090 (2026).","DOI":"10.1016\/j.critrevonc.2025.105090"},{"key":"2026071803250437000_2026.05.29.728710v2.7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ajh.26556","article-title":"Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success","volume":"97","year":"2022","journal-title":"Am J Hematol"},{"key":"2026071803250437000_2026.05.29.728710v2.8","doi-asserted-by":"crossref","unstructured":"M. Latifi , M. Sani , F. Sani , Targeting asymmetric division in cancer stem cells: implications for relapse and resistance. Cancer Cell Int 25, 434 (2025).","DOI":"10.1186\/s12935-025-04052-x"},{"key":"2026071803250437000_2026.05.29.728710v2.9","doi-asserted-by":"crossref","unstructured":"B. V. Le , P. Podszywalow-Bartnicka , S. Maifrede , K. Sullivan-Reed , M. Nieborowska-Skorska , K. Golovine , J. C. Yao , R. Nejati , K. Q. Cai , L. B. Caruso , J. Swatler , M. Dabrowski , Z. Lian , P. Valent , E. M. Paietta , R. L. Levine , H. F. Fernandez , M. S. Tallman , M. R. Litzow , J. Huang , G. A. Challen , D. Link , I. Tempera , M. A. Wasik , K. Piwocka , T. Skorski , TGFbetaR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment. Cell Rep 33, 108221 (2020).","DOI":"10.1016\/j.celrep.2020.108221"},{"key":"2026071803250437000_2026.05.29.728710v2.10","doi-asserted-by":"crossref","unstructured":"M. Wolczyk , R. Serwa , A. Kominek , A. Klejman , J. Milek , M. Chwalek , L. Turos-Korgul , A. Charzynska , M. Dabrowski , M. Dziembowska , T. Skorski , K. Piwocka , P. Podszywalow-Bartnicka , TIAR and FMRP shape pro-survival nascent proteome of leukemia cells in the bone marrow microenvironment. iScience 26, 106543 (2023).","DOI":"10.1016\/j.isci.2023.106543"},{"key":"2026071803250437000_2026.05.29.728710v2.11","doi-asserted-by":"crossref","unstructured":"M. D. Kolba , W. Dudka , M. Zareba-Koziol , A. Kominek , P. Ronchi , L. Turos , P. Chroscicki , J. Wlodarczyk , Y. Schwab , A. Klejman , D. Cysewski , K. Srpan , D. M. Davis , K. Piwocka , Tunneling nanotube-mediated intercellular vesicle and protein transfer in the stroma-provided imatinib resistance in chronic myeloid leukemia cells. Cell Death Dis 10, 817 (2019).","DOI":"10.1038\/s41419-019-2045-8"},{"key":"2026071803250437000_2026.05.29.728710v2.12","doi-asserted-by":"crossref","unstructured":"P. Chroscicki , N. Kasak , D. Dymkowska , L. Turos-Korgul , D. Cysewski , V. Chumak , D. Stepnik , M. Kusio-Kobialka , A. Kominek , M. Lebiedzinska-Arciszewska , A. Krop , J. Szczepanowska , M. Wieckowski , T. Stoklosa , K. Zablocki , K. Piwocka , Stroma-driven horizontal transfer of TCA-related proteins mediates metabolic plasticity and imatinib resistance in chronic myeloid leukemia. Cell Commun Signal 24, 7 (2025).","DOI":"10.1186\/s12964-025-02564-7"},{"key":"2026071803250437000_2026.05.29.728710v2.13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017178"},{"key":"2026071803250437000_2026.05.29.728710v2.14","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0410"},{"key":"2026071803250437000_2026.05.29.728710v2.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-545640"},{"key":"2026071803250437000_2026.05.29.728710v2.16","doi-asserted-by":"crossref","unstructured":"A. Kumar , J. Bhattacharyya , B. G. Jaganathan , Adhesion to stromal cells mediates imatinib resistance in chronic myeloid leukemia through ERK and BMP signaling pathways. Sci Rep 7, 9535 (2017).","DOI":"10.1038\/s41598-017-10373-3"},{"key":"2026071803250437000_2026.05.29.728710v2.17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402179"},{"key":"2026071803250437000_2026.05.29.728710v2.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.06.023"},{"key":"2026071803250437000_2026.05.29.728710v2.19","doi-asserted-by":"crossref","unstructured":"P. Naef , R. Radpour , C. A. Jaeger-Ruckstuhl , N. Bodmer , G. M. Baerlocher , H. Doehner , K. Doehner , C. Riether , A. F. Ochsenbein , IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Sci Signal 16, eadd7705 (2023).","DOI":"10.1126\/scisignal.add7705"},{"key":"2026071803250437000_2026.05.29.728710v2.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.11.006"},{"key":"2026071803250437000_2026.05.29.728710v2.21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/cyto.a.23580","article-title":"Characteristics of live parameters of the HS-5 human bone marrow stromal cell line cocultured with the leukemia cells in hypoxia, for the studies of leukemia-stroma cross-talk","volume":"93","year":"2018","journal-title":"Cytometry A"},{"key":"2026071803250437000_2026.05.29.728710v2.22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/10428194.2018.1471602","article-title":"PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions","volume":"60","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"2026071803250437000_2026.05.29.728710v2.23","doi-asserted-by":"crossref","unstructured":"M. Rudzinska-Radecka , L. Turos-Korgul , D. Mukherjee , P. Podszywalow-Bartnicka , K. Piwocka , J. Guzowski , High-throughput formulation of reproducible 3D cancer microenvironments for drug testing in myeloid leukemia. Biofabrication 17, (2024).","DOI":"10.1101\/2024.01.10.575000"},{"key":"2026071803250437000_2026.05.29.728710v2.24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.008037"},{"key":"2026071803250437000_2026.05.29.728710v2.25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41375-024-02509-y","article-title":"EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CML","volume":"39","year":"2025","journal-title":"Leukemia"},{"key":"2026071803250437000_2026.05.29.728710v2.26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3892\/ijmm.2011.872","article-title":"Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis","volume":"29","year":"2012","journal-title":"Int J Mol Med"},{"key":"2026071803250437000_2026.05.29.728710v2.27","doi-asserted-by":"crossref","unstructured":"P. Podszywalow-Bartnicka , M. Shine , J. Lin , K. M. Neugebauer , Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinib. Sci Adv 12, eaea2475 (2026).","DOI":"10.1126\/sciadv.aea2475"},{"key":"2026071803250437000_2026.05.29.728710v2.28","doi-asserted-by":"crossref","unstructured":"P. Podszywalow-Bartnicka , K. M. Neugebauer , Splicing under stress: A matter of time and place. J Cell Biol 222, (2023).","DOI":"10.1083\/jcb.202311014"},{"key":"2026071803250437000_2026.05.29.728710v2.29","doi-asserted-by":"crossref","unstructured":"H. M. Sung , J. Schott , P. Boss , J. A. Lehmann , M. R. Hardt , D. Lindner , J. Messens , I. Bogeski , U. Ohler , G. Stoecklin , Stress-induced nuclear speckle reorganization is linked to activation of immediate early gene splicing. J Cell Biol 222, (2023).","DOI":"10.1083\/jcb.202111151"},{"key":"2026071803250437000_2026.05.29.728710v2.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07664.x"},{"key":"2026071803250437000_2026.05.29.728710v2.31","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.17.5959-5971.2003"},{"key":"2026071803250437000_2026.05.29.728710v2.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.01.011"},{"key":"2026071803250437000_2026.05.29.728710v2.33","doi-asserted-by":"crossref","unstructured":"I. C. Osma-Garcia , D. Capitan-Sobrino , M. Mouysset , Y. Aubert , O. Maloudi , M. Turner , M. D. Diaz-Munoz , The splicing regulators TIA1 and TIAL1 are required for the expression of the DNA damage repair machinery during B cell lymphopoiesis. Cell Rep 41, 111869 (2022).","DOI":"10.1016\/j.celrep.2022.111869"},{"key":"2026071803250437000_2026.05.29.728710v2.34","doi-asserted-by":"publisher","DOI":"10.4161\/15384101.2014.965013"},{"key":"2026071803250437000_2026.05.29.728710v2.35","doi-asserted-by":"crossref","unstructured":"M. Wolczyk , P. Podszywalow-Bartnicka , L. Bugajski , K. Piwocka , Stress granules assembly affects detection of mRNA in living cells by the NanoFlares; an important aspect of the technology. Biochim Biophys Acta Gen Subj 1861, 1024\u20131035 (2017).","DOI":"10.1016\/j.bbagen.2017.02.010"},{"key":"2026071803250437000_2026.05.29.728710v2.36","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2023.2294222"},{"key":"2026071803250437000_2026.05.29.728710v2.37","doi-asserted-by":"crossref","unstructured":"I. C. Osma-Garcia , O. Maloudi , M. Mouysset , D. Capitan-Sobrino , T.-M. M. Nguyen , Y. Aubert , M. D. Diaz-Mu\u00f1oz , Post-transcriptional regulation by TIA1 and TIAL1 controls the transcriptional program enforcing T cell quiescence. bioRxiv, 2024.2009.2003.608755 (2024).","DOI":"10.1101\/2024.09.03.608755"},{"key":"2026071803250437000_2026.05.29.728710v2.38","doi-asserted-by":"crossref","unstructured":"R. Reyes , J. Alcalde , J. M. Izquierdo , Depletion of T-cell intracellular antigen proteins promotes cell proliferation. Genome Biol 10, R87 (2009).","DOI":"10.1186\/gb-2009-10-8-r87"},{"key":"2026071803250437000_2026.05.29.728710v2.39","doi-asserted-by":"crossref","unstructured":"V. Lafarga , H. M. Sung , K. Haneke , L. Roessig , A. L. Pauleau , M. Bruer , S. Rodriguez-Acebes , A. J. Lopez-Contreras , O. J. Gruss , S. Erhardt , J. Mendez , O. Fernandez-Capetillo , G. Stoecklin , TIAR marks nuclear G2\/M transition granules and restricts CDK1 activity under replication stress. EMBO Rep 20, (2019).","DOI":"10.15252\/embr.201846224"},{"key":"2026071803250437000_2026.05.29.728710v2.40","doi-asserted-by":"crossref","unstructured":"W. Dudka , G. Hoser , S. S. Mondal , L. Turos-Korgul , J. Swatler , M. Kusio-Kobialka , M. Wolczyk , A. Klejman , M. Brewinska-Olchowik , A. Kominek , M. Wiech , M. M. Machnicki , I. Seferynska , T. Stoklosa , K. Piwocka , Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS\/RAF\/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells. BMC Cancer 22, 1254 (2022).","DOI":"10.1186\/s12885-022-10289-w"},{"key":"2026071803250437000_2026.05.29.728710v2.41","doi-asserted-by":"publisher","DOI":"10.4161\/cc.22387"},{"key":"2026071803250437000_2026.05.29.728710v2.42","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.088"},{"key":"2026071803250437000_2026.05.29.728710v2.43","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5411.143"},{"key":"2026071803250437000_2026.05.29.728710v2.44","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1172\/JCI90825","article-title":"Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells","volume":"127","year":"2017","journal-title":"J Clin Invest"},{"key":"2026071803250437000_2026.05.29.728710v2.45","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017295"},{"key":"2026071803250437000_2026.05.29.728710v2.46","doi-asserted-by":"crossref","unstructured":"P. Podszywalow-Bartnicka , Wolczyk, M. , Piwocka, K. , \u201cTargeting of Post-Transcriptional Regulation as Treatment Strategy in Acute Leukemia\u201d in Acute Leukemias, P. P. Piccaluga , Ed. (IntechOpen, 2020).","DOI":"10.5772\/intechopen.94421"},{"key":"2026071803250437000_2026.05.29.728710v2.47","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2713"},{"key":"2026071803250437000_2026.05.29.728710v2.48","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1310"},{"key":"2026071803250437000_2026.05.29.728710v2.49","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21659"},{"key":"2026071803250437000_2026.05.29.728710v2.50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3727\/096504009789745557","article-title":"Hemin counteracts the repression of Bcl-2 and NrF2 genes and the cell killing induced by imatinib in human Bcr-Abl(+) CML cells","volume":"17","year":"2009","journal-title":"Oncol Res"},{"key":"2026071803250437000_2026.05.29.728710v2.51","doi-asserted-by":"crossref","first-page":"67406","DOI":"10.18632\/oncotarget.18684","article-title":"Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"2026071803250437000_2026.05.29.728710v2.52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.267666"},{"key":"2026071803250437000_2026.05.29.728710v2.53","doi-asserted-by":"crossref","first-page":"e113141","DOI":"10.1371\/journal.pone.0113141","article-title":"Long-term reduction of T-cell intracellular antigens reveals a transcriptome associated with extracellular matrix and cell adhesion components","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"2026071803250437000_2026.05.29.728710v2.54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.43"},{"key":"2026071803250437000_2026.05.29.728710v2.55","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20101030"},{"key":"2026071803250437000_2026.05.29.728710v2.56","doi-asserted-by":"crossref","unstructured":"L. Yang , H. Sun , R. Wang , D. Yang , Q. Gu , G. Zhao , L. Sun , X. Chen , J. Lv , X. Lin , J. Cheng , M. L. Akhtar , M. Zhang , J. Zang , X. Shi , Z. Zhang , L. Deng , L. Xiao , L. Yue , W. Dong , Q. Jiang , F. Han , Y. Li , H. Nie , Metabolic orchestration driven by GGCT: diverting glutamine to glutathione biosynthesis while enhancing glucose anaplerosis for tumor proliferation. Cell Death Dis 17, (2026).","DOI":"10.1038\/s41419-026-08619-y"},{"key":"2026071803250437000_2026.05.29.728710v2.57","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/onc.2015.270","article-title":"Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells","volume":"35","year":"2016","journal-title":"Oncogene"},{"key":"2026071803250437000_2026.05.29.728710v2.58","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011437"},{"key":"2026071803250437000_2026.05.29.728710v2.59","first-page":"e10716","article-title":"Sorting-free metabolic profiling uncovers the vulnerability of fatty acid beta-oxidation in in vitro quiescence models","volume":"18","year":"2022","journal-title":"Mol Syst Biol"},{"key":"2026071803250437000_2026.05.29.728710v2.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.06.001"},{"key":"2026071803250437000_2026.05.29.728710v2.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.12.013"},{"key":"2026071803250437000_2026.05.29.728710v2.62","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1158\/0008-5472.CAN-23-1006","article-title":"Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold","volume":"83","year":"2023","journal-title":"Cancer Res"},{"key":"2026071803250437000_2026.05.29.728710v2.63","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0441"},{"key":"2026071803250437000_2026.05.29.728710v2.64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081297"},{"key":"2026071803250437000_2026.05.29.728710v2.65","doi-asserted-by":"crossref","unstructured":"K. Han , J. Li , S. Yin , H. Hu , C. Zhao , Medium-Chain Fatty Acids Selectively Sensitize Cancer Cells to Ferroptosis by Inducing CD36 and ACSL4. Nutrients 17, (2025).","DOI":"10.3390\/nu17050794"},{"key":"2026071803250437000_2026.05.29.728710v2.66","doi-asserted-by":"crossref","unstructured":"L. Closset , J. P. Foy , L. Louadj , E. Pramil , E. Marangoni , I. Bieche , M. Sabbah , CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis. Cell Death Dis 17, 219 (2026).","DOI":"10.1038\/s41419-026-08460-3"},{"key":"2026071803250437000_2026.05.29.728710v2.67","doi-asserted-by":"crossref","unstructured":"E. Walejewska , J. Idaszek , M. Heljak , A. Chlanda , E. Choinska , V. Hasirci , W. Swieszkowski , The effect of introduction of filament shift on degradation behaviour of PLGA-and PLCL-based scaffolds fabricated via additive manufacturing. Polym Degrad Stabil 171, (2020).","DOI":"10.1016\/j.polymdegradstab.2019.109030"},{"key":"2026071803250437000_2026.05.29.728710v2.68","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1002\/term.2310","article-title":"Three-dimensional printed polycaprolactone-based scaffolds provide an advantageous environment for osteogenic differentiation of human adipose-derived stem cells","volume":"12","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"2026071803250437000_2026.05.29.728710v2.69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026071803250437000_2026.05.29.728710v2.70","doi-asserted-by":"publisher","DOI":"10.1038\/ng1180"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.29.728710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:25:27Z","timestamp":1784370327000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.05.29.728710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":70,"URL":"https:\/\/doi.org\/10.64898\/2026.05.29.728710","relation":{},"subject":[],"published":{"date-parts":[[2026,5,30]]},"subtype":"preprint"}}